Your browser doesn't support javascript.
loading
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
Ebbo, Mikael; Grados, Aurélie; Samson, Maxime; Groh, Matthieu; Loundou, Anderson; Rigolet, Aude; Terrier, Benjamin; Guillaud, Constance; Carra-Dallière, Clarisse; Renou, Frédéric; Pozdzik, Agnieszka; Labauge, Pierre; Palat, Sylvain; Berthelot, Jean-Marie; Pennaforte, Jean-Loup; Wynckel, Alain; Lebas, Céline; Le Gouellec, Noémie; Quémeneur, Thomas; Dahan, Karine; Carbonnel, Franck; Leroux, Gaëlle; Perlat, Antoinette; Mathian, Alexis; Cacoub, Patrice; Hachulla, Eric; Costedoat-Chalumeau, Nathalie; Harlé, Jean-Robert; Schleinitz, Nicolas.
Afiliación
  • Ebbo M; Department of Internal Medicine, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France.
  • Grados A; Department of Internal Medicine, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France.
  • Samson M; Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France.
  • Groh M; Department of Internal Medicine, Hôpital Cochin, AP-HP, Centre National de Référence Maladies Systémiques et Auto-immunes Rares, Université René-Descartes Paris V, Sorbonne Paris Cité, Paris, France.
  • Loundou A; Unité d'Aide Méthodologique, Aix-Marseille Université, AP-HM, Marseille, France.
  • Rigolet A; Department of Internal Medicine and Clinical Immunology, AP-HP, Hôpital La Pitié-Salpêtrière; DHUI2B, Université Pierre et Marie Curie Paris VI, Paris, France.
  • Terrier B; Department of Internal Medicine, Hôpital Cochin, AP-HP, Centre National de Référence Maladies Systémiques et Auto-immunes Rares, Université René-Descartes Paris V, Sorbonne Paris Cité, Paris, France.
  • Guillaud C; Department of Internal Medicine, Hôpital Henri Mondor, AP-HP, Créteil, France.
  • Carra-Dallière C; Department of Neurology, CHRU de Montpellier, Montpellier, France.
  • Renou F; Department of Internal Medicine, CHU La Réunion site Félix Guyon, Saint-Denis, La Réunion, France.
  • Pozdzik A; Department of Nephrology, Erasme Hospital, Cliniques Universitaires de Bruxelles, Bruxelles, Belgium.
  • Labauge P; Department of Neurology, CHRU de Montpellier, Montpellier, France.
  • Palat S; Department of Internal Medicine, CHU Limoges, Limoges, France.
  • Berthelot JM; Department of Rheumatology, CHU Nantes, Nantes, France.
  • Pennaforte JL; Department of Internal Medicine, CHU de Reims, Reims, France.
  • Wynckel A; Department of Nephrology, CHU de Reims, Reims, France.
  • Lebas C; Department of Nephrology, CHRU de Lille, Lille, France.
  • Le Gouellec N; Department of Nephrology and Internal Medicine, CH Valenciennes, Valenciennes, France.
  • Quémeneur T; Department of Nephrology and Internal Medicine, CH Valenciennes, Valenciennes, France.
  • Dahan K; Department of Nephrology, Hôpital Tenon, AP-HP, Paris, France.
  • Carbonnel F; Department of Gastro-enterology, CHU Bicêtre, Le Kremlin Bicêtre, France.
  • Leroux G; Department of Internal Medicine and Clinical Immunology, AP-HP, Hôpital La Pitié-Salpêtrière; DHUI2B, Université Pierre et Marie Curie Paris VI, Paris, France.
  • Perlat A; Department of Internal Medicine, Hôpital Sud, CHU de Rennes, Rennes, France.
  • Mathian A; Department of Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, Centre National de Référence Maladies Systémiques et Auto-immunes Rares, Université Pierre et Marie Curie Paris VI, Paris, France.
  • Cacoub P; Department of Internal Medicine and Clinical Immunology, AP-HP, Hôpital La Pitié-Salpêtrière; DHUI2B, Université Pierre et Marie Curie Paris VI, Paris, France.
  • Hachulla E; National Referral Centre for Auto-immune and Systemic Diseases, Department of Internal Medicine, Huriez Hospital, Université de Lille, Lille, France.
  • Costedoat-Chalumeau N; Department of Internal Medicine, Hôpital Cochin, AP-HP, Centre National de Référence Maladies Systémiques et Auto-immunes Rares, Université René-Descartes Paris V, Sorbonne Paris Cité, Paris, France.
  • Harlé JR; Department of Internal Medicine, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France.
  • Schleinitz N; Department of Internal Medicine, Hôpital de la Timone, AP-HM, Aix-Marseille Université, Marseille, France.
PLoS One ; 12(9): e0183844, 2017.
Article en En | MEDLINE | ID: mdl-28915275
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inmunoglobulina G / Bases de Datos Factuales / Rituximab Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inmunoglobulina G / Bases de Datos Factuales / Rituximab Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Francia